Shares of Waters Co. (NYSE:WAT) have earned an average rating of “Hold” from the sixteen brokerages that are covering the firm, MarketBeat reports. Four equities research analysts have rated the stock with a sell recommendation, ten have issued a hold recommendation and one has given a buy recommendation to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $210.58.
Several brokerages have issued reports on WAT. Zacks Investment Research downgraded Waters from a “strong-buy” rating to a “hold” rating in a research report on Friday, April 12th. ValuEngine downgraded Waters from a “buy” rating to a “hold” rating in a research report on Wednesday, April 24th. UBS Group cut their price objective on Waters from $248.00 to $230.00 and set a “neutral” rating for the company in a research report on Wednesday, April 24th. Cleveland Research downgraded Waters from a “neutral” rating to an “underperform” rating in a research report on Wednesday, June 12th. Finally, Barclays cut their price objective on Waters from $218.00 to $210.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 24th.
Several hedge funds have recently added to or reduced their stakes in WAT. Stone Ridge Asset Management LLC increased its holdings in Waters by 7.0% in the fourth quarter. Stone Ridge Asset Management LLC now owns 2,535 shares of the medical instruments supplier’s stock valued at $478,000 after purchasing an additional 166 shares during the last quarter. Nisa Investment Advisors LLC grew its stake in Waters by 4.2% in the first quarter. Nisa Investment Advisors LLC now owns 46,494 shares of the medical instruments supplier’s stock valued at $11,703,000 after acquiring an additional 1,880 shares during the period. Kinneret Advisory LLC acquired a new position in Waters in the fourth quarter valued at about $1,055,000. Ontario Teachers Pension Plan Board grew its stake in Waters by 6.7% in the fourth quarter. Ontario Teachers Pension Plan Board now owns 173,146 shares of the medical instruments supplier’s stock valued at $32,664,000 after acquiring an additional 10,815 shares during the period. Finally, IFM Investors Pty Ltd grew its stake in Waters by 10.5% in the first quarter. IFM Investors Pty Ltd now owns 4,985 shares of the medical instruments supplier’s stock valued at $1,255,000 after acquiring an additional 472 shares during the period. Institutional investors own 92.57% of the company’s stock.
WAT stock traded down $0.41 during trading on Friday, hitting $210.85. The company had a trading volume of 17,071 shares, compared to its average volume of 608,640. The firm’s fifty day moving average is $208.01. The company has a current ratio of 3.44, a quick ratio of 2.89 and a debt-to-equity ratio of 1.15. The stock has a market capitalization of $14.76 billion, a P/E ratio of 25.47, a P/E/G ratio of 2.24 and a beta of 1.08. Waters has a fifty-two week low of $167.93 and a fifty-two week high of $255.21.
Waters (NYSE:WAT) last announced its quarterly earnings results on Tuesday, April 23rd. The medical instruments supplier reported $1.60 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.73 by ($0.13). Waters had a net margin of 24.59% and a return on equity of 39.64%. The company had revenue of $513.90 million during the quarter, compared to analyst estimates of $545.82 million. During the same period in the prior year, the firm earned $1.59 EPS. Waters’s quarterly revenue was down 3.2% compared to the same quarter last year. As a group, analysts expect that Waters will post 9.11 earnings per share for the current year.
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Read More: Hedge Funds
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.